for Welbutrin (bupropion), wch is prescribed for depression, but not Zyban (bupropion), the same drug marketed for smoking cessation. You wonder whether it is “insurance fraud” to save the patient money by treating smoking cessation with a prescription for Welbutrin, given that the medication and dosing is the same as Zyban. Analyze the etcal choice inherent by the following: 1. is ts a legal rather than etcal question? 2. Consider laws governing: a. scope of practice b. kickbacks c. billing Medicare, Medicaid, and commercial insurers Who is benefiting from ts situation and how? What would the etcal practitioner do?